Major global pharmaceutical companies such as Eli Lilly and Novartis have increased their research and development spending, according to the Global Innovation Index 2024, a report by the World Intellectual Property Office (WIPO).
Informatie preluata din publicatia "Bursa" - citeste integral articolul - click aici
Web Design by Dow Media | Gazduire Web by SpeedHost.ro